SAMPRE (14)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE updates the Enhanced Surveillance Measure framework with 2 new securities added, movement of securities between ESM stages, and 24 … | |||||||||||||||
BSE updates the Enhanced Surveillance Measure framework with 2 new securities added, movement of securities between ESM stages, and 24 securities exiting the framework effective January 12, 2026.
| |||||||||||||||
BSE updates Enhanced Surveillance Measure framework effective January 12, 2026, with 2 securities newly shortlisted, 1 moving to higher … | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework effective January 12, 2026, with 2 securities newly shortlisted, 1 moving to higher stage, 12 moving to lower stage, and 24 securities moving out of ESM framework.
| |||||||||||||||
BSE announces new ISIN INE375C01022 for SAMPRE NUTRITIONS LTD (530617) effective from ex-date November 14, 2025, following sub-division of … | |||||||||||||||
BSE announces new ISIN INE375C01022 for SAMPRE NUTRITIONS LTD (530617) effective from ex-date November 14, 2025, following sub-division of equity shares from Rs.10/- to Rs.5/-.
| |||||||||||||||
BSE announces new ISIN INE375C01022 for SAMPRE NUTRITIONS LTD effective November 14, 2025, following sub-division of equity shares from … | |||||||||||||||
BSE announces new ISIN INE375C01022 for SAMPRE NUTRITIONS LTD effective November 14, 2025, following sub-division of equity shares from Rs.10/- to Rs.5/-.
| |||||||||||||||
BSE lists 8,40,000 new equity shares of Sampre Nutritions Ltd. issued on preferential basis pursuant to warrant conversion, effective … | |||||||||||||||
BSE lists 8,40,000 new equity shares of Sampre Nutritions Ltd. issued on preferential basis pursuant to warrant conversion, effective November 11, 2025.
| |||||||||||||||
8,40,000 equity shares of Sampre Nutritions Ltd. issued at premium on preferential basis pursuant to warrant conversion, listed for trading … | |||||||||||||||
8,40,000 equity shares of Sampre Nutritions Ltd. issued at premium on preferential basis pursuant to warrant conversion, listed for trading from November 11, 2025.
| |||||||||||||||
BSE announces revision of price bands for 36 securities effective November 10, 2025, with bands ranging from 1% to 20%. | |||||||||||||||
BSE announces revision of price bands for 36 securities effective November 10, 2025, with bands ranging from 1% to 20%.
| |||||||||||||||
BSE circular detailing securities being added to, moved within, or removed from the Enhanced Surveillance Measure framework effective … | |||||||||||||||
BSE circular detailing securities being added to, moved within, or removed from the Enhanced Surveillance Measure framework effective November 10, 2025.
| |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with additions, removals, and stage changes for multiple securities effective November … | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with additions, removals, and stage changes for multiple securities effective November 10, 2025.
| |||||||||||||||
Sampre Nutritions Limited revises the record date for split/sub-division and bonus issue of equity shares from 11 November 2025 to 14 … | |||||||||||||||
Sampre Nutritions Limited revises the record date for split/sub-division and bonus issue of equity shares from 11 November 2025 to 14 November 2025.
| |||||||||||||||